A clinical study of body odor for test product

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0003498

Enrollment

Registered

2019-02-13

Start date

2017-03-06

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(cosmetic) : product 1)Body form product 2) Placebo active ingredient: Odor-X 1.0&#37

, Natural Antimicrobial Complex 1.0&#37

According to sponsor’s recommendations, the test product 1 and test product 2 were applied. (test product1 -&gt

test product2 or test product2-&gt

test product1) Once a day for four days using the product, amount of product was taken. using the product with sufficiently frothy and taking a shower with water.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Non-smoker, Healthy male and females; 50 to 61 years of age 2.The subject is apprised regarding the purpose and the protocol of the study; signed informed consent is obtained 3.Volunteers should be cooperative and available for follow-up during the study period

Exclusion criteria

Exclusion criteria: 1.Pregnancy or nursing condition 2.Use of anti-inflammatories, corticoids, steroid within 1 month 3.Participation in a previous study without an appropriate intervening period (three months) between studies 4.Sensitivity or hypersensitivity skin 5.Subjects having marks, blemishes or nevi or presenting with existing sun damage in the test area 6.A chronic sickness (diabetes, asthma, high blood-pressure) 7.Atopic dermatitis 8.Any difficult which may interfere with the aim of the study as the judgement of the investigator

Design outcomes

Primary

Measure	Time frame
Sensory evaluation of body odor test;Gas chromatography–mass spectrometry(GC/MS) analysis;Quantitative analysis of odor molecule by zNose®	—

Secondary

Measure	Time frame
Electroencephalography(EEG) & Electromyography(EMG) measurement;Evaluation of axillary microbe	—

Countries

Korea, Republic of

Contacts

Public ContactYoung seo

Dermapro

youngkyoungseo@gmail.com+82-2-597-5435

Outcome results